The expression levels of PARP-1 and associated genes are generally higher in various cancers, such as breast cancer, ovarian cancer, endometrial cancer, lung cancer, and prostate cancer, when compared to normal tissues [14]. This evidence concerns the gene PARP1 and cancer.